 immunostaining human breast tumors relationship prognosis labeling nonmalignant breast tissues breast carcinomas ten random high-power fields section planes RC evaluation area labeling density HDC procedures rs fractions nonmalignant tissues mean RC HDC carcinomas mean RC HDC labeling pT stage axillary lymph node status tumor grading receptor status medians methods RC HDC cutoff points different curves overall disease-free survival median follow-up months Cox analysis independent effect labeling contrast reactivity independent prognostic value cutoff level